Neihulizumab
Neihulizumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Neihulizumab is a novel immune checkpoint agonistic antibody that binds to human CD162 (PSGL-1), thereby preferentially inducing apoptosis in late stage activated T cells.
| Trade Name | Neihulizumab |
| Generic | Neihulizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Neihulizumab
